ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.
(RTTNews) - Resmed Inc (RMD) Wednesday said it has published a meta analysis in The Lancet Respiratory Medicine showing that CPAP therapy significantly reduces the risk of death for people with ...
The study, led by global experts in sleep and respiratory medicine and supported by Resmed, found that people with OSA who use CPAP therapy have: A 37% lower risk of dying from any cause compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback